|
|
||||||||


*
Amgen Institute and Ontario Cancer Institute and
Departments of Immunology and Medical Biophysics, University of Toronto, Toronto, Ontario, Canada; and
Ontario Cancer Institute, Department of Oncologic Pathology, Toronto, Ontario, Canada
Caspase-3 is essential for Fas-mediated apoptosis in vitro. We investigated the role of caspase-3 in Fas-mediated cell death in vivo by injecting caspase-3-deficient mice with agonistic anti-Fas Ab. Wild-type controls died rapidly of fulminant hepatitis, whereas the survival of caspase-3-/- mice was increased due to a delay in hepatocyte cell death. Bcl-2 expression in the liver was dramatically decreased in wild-type mice following anti-Fas injection, but was unchanged in caspase-3-/- mice. Hepatocytes from anti-Fas-injected wild-type, but not caspase-3-/-, mice released cytochrome c into the cytoplasm. Western blotting confirmed the lack of caspase-3-mediated cleavage of Bcl-2. Presumably the presence of intact Bcl-2 in caspase-3-/- hepatocytes prevents the release of cytochrome c from the mitochondria, a required step for the mitochondrial death pathway. We also show by Western blot that Bcl-xL, caspase-9, caspase-8, and Bid are processed by caspase-3 in injected wild-type mice but that this processing does not occur in caspase-3-/- mice. This study thus provides novel in vivo evidence that caspase-3, conventionally known for its downstream effector function in apoptosis, also modifies Bcl-2 and other upstream proteins involved in the regulation of Fas-mediated apoptosis.
This article has been cited by other articles:
![]() |
A. Radziszewska, S. A. Schroer, D. Choi, P. Tajmir, N. Radulovich, J. C. Ho, L. Wang, N. Liadis, R. Hakem, M.-S. Tsao, et al. Absence of Caspase-3 Protects Pancreatic {beta}-Cells from c-Myc-induced Apoptosis without Leading to Tumor Formation J. Biol. Chem., April 17, 2009; 284(16): 10947 - 10956. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Liadis, L. Salmena, E. Kwan, P. Tajmir, S. A. Schroer, A. Radziszewska, X. Li, L. Sheu, M. Eweida, S. Xu, et al. Distinct In Vivo Roles of Caspase-8 in {beta}-Cells in Physiological and Diabetes Models Diabetes, September 1, 2007; 56(9): 2302 - 2311. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Liadis, K. Murakami, M. Eweida, A. R. Elford, L. Sheu, H. Y. Gaisano, R. Hakem, P. S. Ohashi, and M. Woo Caspase-3-Dependent {beta}-Cell Apoptosis in the Initiation of Autoimmune Diabetes Mellitus Mol. Cell. Biol., May 1, 2005; 25(9): 3620 - 3629. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. K. Nussbaum and J. L. Whitton The Contraction Phase of Virus-Specific CD8+ T Cells Is Unaffected by a Pan-Caspase Inhibitor J. Immunol., December 1, 2004; 173(11): 6611 - 6618. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. E. De Paepe, Q. Mao, M. Embree-Ku, L. P. Rubin, and F. I. Luks Fas/FasL-mediated apoptosis in perinatal murine lungs Am J Physiol Lung Cell Mol Physiol, October 1, 2004; 287(4): L730 - L742. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Zhang, J. Taylor, D. Luther, J. Johnston, S. Murray, J. R. Wyatt, A. T. Watt, S. Koo, C. York-DeFalco, K. Stecker, et al. Antisense Oligonucleotide Inhibition of Bcl-xL and Bid Expression in Liver Regulates Responses in a Mouse Model of Fas-Induced Fulminant Hepatitis J. Pharmacol. Exp. Ther., October 1, 2003; 307(1): 24 - 33. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Sarig, Y. Zaltsman, R. C. Marcellus, R. Flavell, T. W. Mak, and A. Gross BID-D59A Is a Potent Inducer of Apoptosis in Primary Embryonic Fibroblasts J. Biol. Chem., March 14, 2003; 278(12): 10707 - 10715. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Jodo, J. T. Kung, S. Xiao, D. V. Chan, S. Kobayashi, M. Tateno, R. Lafyatis, and S.-T. Ju Anti-CD95-induced Lethality Requires Radioresistant Fcgamma RII+ Cells. A NOVEL MECHANISM FOR FULMINANT HEPATIC FAILURE J. Biol. Chem., February 21, 2003; 278(9): 7553 - 7557. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Li, Y. Zhao, X. He, T.-H. Kim, D. K. Kuharsky, H. Rabinowich, J. Chen, C. Du, and X.-M. Yin Relief of Extrinsic Pathway Inhibition by the Bid-dependent Mitochondrial Release of Smac in Fas-mediated Hepatocyte Apoptosis J. Biol. Chem., July 19, 2002; 277(30): 26912 - 26920. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Okada, W.-K. Suh, J. Jin, M. Woo, C. Du, A. Elia, G. S. Duncan, A. Wakeham, A. Itie, S. W. Lowe, et al. Generation and Characterization of Smac/DIABLO-Deficient Mice Mol. Cell. Biol., May 15, 2002; 22(10): 3509 - 3517. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. C. Hoglen, B. P. Hirakawa, C. D. Fisher, S. Weeks, A. Srinivasan, A. M. Wong, K. L. Valentino, K. J. Tomaselli, X. Bai, D. S. Karanewsky, et al. Characterization of the Caspase Inhibitor IDN-1965 in a Model of Apoptosis-Associated Liver Injury J. Pharmacol. Exp. Ther., April 12, 2001; 297(2): 811 - 818. [Abstract] [Full Text] |
||||
![]() |
N. Droin, F. Bichat, C. Rebe, A. Wotawa, O. Sordet, A. Hammann, R. Bertrand, and E. Solary Involvement of caspase-2 long isoform in Fas-mediated cell death of human leukemic cells Blood, March 15, 2001; 97(6): 1835 - 1844. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. G. Ekert, J. Silke, C. J. Hawkins, A. M. Verhagen, and D. L. Vaux Diablo Promotes Apoptosis by Removing Miha/Xiap from Processed Caspase 9 J. Cell Biol., February 5, 2001; 152(3): 483 - 490. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Matsushita, Y. Wu, J. Qiu, L. Lang-Lazdunski, L. Hirt, C. Waeber, B. T. Hyman, J. Yuan, and M. A. Moskowitz Fas Receptor and Neuronal Cell Death after Spinal Cord Ischemia J. Neurosci., September 15, 2000; 20(18): 6879 - 6887. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Latta, G. Kunstle, M. Leist, and A. Wendel Metabolic Depletion of Atp by Fructose Inversely Controls Cd95- and Tumor Necrosis Factor Receptor 1-Mediated Hepatic Apoptosis J. Exp. Med., June 5, 2000; 191(11): 1975 - 1986. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. Paris, H. Grassme, A. Cremesti, J. Zager, Y. Fong, A. Haimovitz-Friedman, Z. Fuks, E. Gulbins, and R. Kolesnick Natural Ceramide Reverses Fas Resistance of Acid Sphingomyelinase-/- Hepatocytes J. Biol. Chem., March 9, 2001; 276(11): 8297 - 8305. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Machida, K. Tsukiyama-Kohara, E. Seike, S. Tone, F. Shibasaki, M. Shimizu, H. Takahashi, Y. Hayashi, N. Funata, C. Taya, et al. Inhibition of Cytochrome c Release in Fas-mediated Signaling Pathway in Transgenic Mice Induced to Express Hepatitis C Viral Proteins J. Biol. Chem., April 6, 2001; 276(15): 12140 - 12146. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |